⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of MSD Sharp & Dohme GmbH and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
MSD Sharp & Dohme GmbH
↗Rahway, New Jersey, USA (Global); Haar, Germany (MSD Germany)
MSD (known as Merck & Co. in the U.S. and Canada) is a premier, research-intensive global biopharmaceutical company. For over 130 years, it has been at the forefront of research to deliver innovative health solutions, focusing on the prevention and treatment of diseases in people and animals through medicines, vaccines, and animal health products.
The company maintains a massive global footprint, particularly in oncology, vaccines, and infectious diseases. It operates an extensive manufacturing network and invests heavily in R&D to address unmet medical needs, with its German subsidiary, MSD Sharp & Dohme GmbH, serving as a key regional entity.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Oncology, Vaccines, Infectious Diseases
SIZE & FINANCIALS
Employees:10000+
Revenue:$65B
Founded:1891
Ownership:public
Status:operating
STOCK
Exchange:NYSE
Ticker:MRK
Market Cap:N/A
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Monoclonal antibody, Antibody-drug conjugate, Vaccines, RNA technology
Active Trials:0
Trial Phases:Phase 2: 50 | Phase 3: 30
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:AstraZeneca (Lynparza collaboration), Daiichi Sankyo (Oncology collaborations)
COMPETITION
Position:Leader
Competitors:Pfizer, Bristol Myers Squibb, Roche, Novartis
LEADERSHIP
Key Executives:
Robert M. Davis - CEO
LINKS
Website:msd.de
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with MSD Sharp & Dohme GmbH. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.